STAT3 and ovarian carcinoma: Additionally, some researchers demonstrated that multidrug resistance was consistent with STAT3 mRNA overexpression in cisplatin-resistant lung cancer cells [25] and STAT3 activity was found to be specifically elevated in drug-resistant neuroblastoma and ovarian cancer cells, while not in relevant drug sensitive cells [26].